{"nct_id":"NCT01462357","title":"Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females","status":"COMPLETED","status_verified_date":"2019-10","start_date":"2011-11-21","start_date_type":"ACTUAL","primary_completion_date":"2015-10-27","primary_completion_date_type":"ACTUAL","completion_date":"2015-10-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}